Hantz Financial Services Inc. lowered its stake in shares of MetLife, Inc. (NYSE:MET – Free Report) by 3.9% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 181,890 shares of the financial services provider’s stock after selling 7,317 shares during the period. Hantz Financial Services Inc.’s holdings in MetLife were worth $15,002,000 at the end of the most recent reporting period.
Several other institutional investors have also recently made changes to their positions in the stock. Vinva Investment Management Ltd lifted its position in shares of MetLife by 10.8% during the third quarter. Vinva Investment Management Ltd now owns 27,582 shares of the financial services provider’s stock worth $2,275,000 after acquiring an additional 2,696 shares in the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its position in shares of MetLife by 1.5% in the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 4,548,725 shares of the financial services provider’s stock worth $375,179,000 after buying an additional 68,579 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank raised its position in shares of MetLife by 20.6% in the third quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 763,521 shares of the financial services provider’s stock worth $62,975,000 after buying an additional 130,393 shares in the last quarter. First Commonwealth Financial Corp PA raised its position in shares of MetLife by 0.8% in the third quarter. First Commonwealth Financial Corp PA now owns 16,675 shares of the financial services provider’s stock worth $1,375,000 after buying an additional 133 shares in the last quarter. Finally, CreativeOne Wealth LLC raised its position in shares of MetLife by 27.6% in the third quarter. CreativeOne Wealth LLC now owns 8,959 shares of the financial services provider’s stock worth $739,000 after buying an additional 1,938 shares in the last quarter. Hedge funds and other institutional investors own 89.81% of the company’s stock.
Wall Street Analysts Forecast Growth
A number of equities research analysts recently issued reports on the company. Barclays lowered their price objective on MetLife from $91.00 to $90.00 and set an “overweight” rating on the stock in a research report on Thursday, October 31st. Wells Fargo & Company increased their price objective on MetLife from $92.00 to $93.00 and gave the stock an “overweight” rating in a research report on Tuesday, November 5th. Jefferies Financial Group increased their price objective on MetLife from $89.00 to $95.00 and gave the stock a “buy” rating in a research report on Friday, September 27th. Piper Sandler raised their price target on MetLife from $85.00 to $92.00 and gave the company an “overweight” rating in a research report on Wednesday, October 2nd. Finally, TD Cowen raised their price target on MetLife from $97.00 to $99.00 and gave the company a “buy” rating in a research report on Wednesday. Fourteen research analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, the company presently has a consensus rating of “Buy” and a consensus target price of $88.62.
MetLife Stock Up 0.6 %
Shares of NYSE:MET opened at $88.25 on Friday. The stock’s 50-day moving average price is $83.19 and its 200-day moving average price is $76.46. MetLife, Inc. has a 12-month low of $62.89 and a 12-month high of $89.05. The stock has a market capitalization of $61.11 billion, a P/E ratio of 17.79, a price-to-earnings-growth ratio of 0.81 and a beta of 1.05. The company has a current ratio of 0.16, a quick ratio of 0.16 and a debt-to-equity ratio of 0.51.
MetLife Announces Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Monday, December 16th. Stockholders of record on Tuesday, November 5th will be paid a dividend of $0.545 per share. The ex-dividend date of this dividend is Tuesday, November 5th. This represents a $2.18 dividend on an annualized basis and a dividend yield of 2.47%. MetLife’s dividend payout ratio (DPR) is currently 43.95%.
MetLife Profile
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
Recommended Stories
- Five stocks we like better than MetLife
- Russell 2000 Index, How Investors Use it For Profitable Trading
- Eli Lilly, Pfizer, and AstraZeneca: 2025 Vaccine Makers to Watch
- How to Use Stock Screeners to Find Stocks
- DICK’S Sporting Goods: The Under-the-Radar Buy-and-Hold Winner
- What is Forex and How Does it Work?
- 2 Cheap Quantum Computing Stocks to Buy Instead of Chasing IonQ
Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:MET – Free Report).
Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.